Literature DB >> 7042769

Imipramine treatment of depressed children: a double-blind pilot study.

T A Petti, W Law.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7042769

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  7 in total

Review 1.  Pharmacological treatment of depression in children and adolescents.

Authors:  R L Findling; M D Reed; J L Blumer
Journal:  Paediatr Drugs       Date:  1999 Jul-Sep       Impact factor: 3.022

2.  Efficacy of antidepressants in child and adolescent depression: a meta-analytic study.

Authors:  K Papanikolaou; C Richardson; A Pehlivanidis; Z Papadopoulou-Daifoti
Journal:  J Neural Transm (Vienna)       Date:  2005-08-03       Impact factor: 3.575

3.  Treatment with escitalopram but not desipramine decreases escape latency times in a learned helplessness model using juvenile rats.

Authors:  Abbey L Reed; Jeffrey C Anderson; David B Bylund; Frederick Petty; Hesham El Refaey; H Kevin Happe
Journal:  Psychopharmacology (Berl)       Date:  2009-04-22       Impact factor: 4.530

4.  Efficacy of tricyclic drugs in treating child and adolescent depression: a meta-analysis.

Authors:  P Hazell; D O'Connell; D Heathcote; J Robertson; D Henry
Journal:  BMJ       Date:  1995-04-08

5.  A comparison of the relative efficacy of self-control therapy and a behavioral problem-solving therapy for depression in children.

Authors:  K D Stark; W M Reynolds; N J Kaslow
Journal:  J Abnorm Child Psychol       Date:  1987-03

Review 6.  Tricyclic drugs for depression in children and adolescents.

Authors:  Philip Hazell; Mohsen Mirzaie
Journal:  Cochrane Database Syst Rev       Date:  2013-06-18

Review 7.  Are child and adolescent responses to placebo higher in major depression than in anxiety disorders? A systematic review of placebo-controlled trials.

Authors:  David Cohen; Emmanuelle Deniau; Alejandro Maturana; Marie-Laure Tanguy; Nicolas Bodeau; Réal Labelle; Jean-Jacques Breton; Jean-Marc Guile
Journal:  PLoS One       Date:  2008-07-09       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.